Biome Australia Limited

BIO

AU0000184137

Pharmaceuticals

Delayed Australian S.E. Other stock markets 09:05:45 2026-04-20 pm EDT			5-day change	1st Jan Change
0.3400 ^AUD	-2.86%		-2.86%	-19.05%

Mar. 22	Biome Australia Limited(ASX:BIO) dropped from S&P/ASX Emerging Companies Index	CI
Feb. 24	Biome Australia Limited, H1 2026 Earnings Call, Feb 25, 2026

Biome Australia Limited Reports Unaudited Revenue Results for the Second Quarter and Half Year of 2024

Published on 01/01/2024 at 04:25 pm EST

S&P Capital IQ

BIOME AUSTRALIA LIMITED

-2.86%

Biome Australia Limited reported unaudited revenue results for the second quarter and half year of 2024. For the quarter, the company reported sales revenue of ~$3.3 million.

For the half year, the company reported sales revenue of ~$6 million.

Latest news about Biome Australia Limited

Mar. 22	Biome Australia Limited(ASX:BIO) dropped from S&P/ASX Emerging Companies Index	CI
Feb. 24	Biome Australia Limited, H1 2026 Earnings Call, Feb 25, 2026
Feb. 22	Biome Australia Limited Reports Earnings Results for the Half Year Ended December 31, 2025	CI
Feb. 02	Biome Australia Secures Ethics Approval for Probiotic Strain Human Clinical Trial	MT
Feb. 02	Biome Australia says ethics approval granted for BMB18 human clinical trial	RE
Feb. 01	Biome Australia Agrees on Commercial Terms for Distribution of Product Range in Canada	MT
Feb. 01	Biome Australia says co expands Canadian practitioner channel with Fullscript partnership	RE
Jan. 26	Biome Australia posts H1 ebitda of AUD 1.48 million	RE
Jan. 04	Biome Australia says Q2 FY26 revenue A$6.48 million	RE
Jan. 04	Biome Australia Posts Higher Fiscal Q2 2026 Revenue, Shares Up 11%	MT
Dec. 15	Biome Australia Submits First Human Clinical Trial for Probiotic Strain for Ethics Approval	MT
Dec. 03	Biome Australia Appoints CFO	MT
Dec. 03	Biome Australia appoints incoming chief financial officer	RE
Dec. 03	Biome Australia Limited Announces Chief Financial Officer Changes	CI
Nov. 26	Biome Australia Limited - Shareholder/Analyst Call

Chart Biome Australia Limited

Duration

Period

BIO: Dynamic Chart

Company Profile

Biome Australia Ltd is an Australia-based microbiome health company. The Company develops, licenses, commercializes and markets evidence-based live biotherapeutics (probiotics) and complementary medicines. It develops, manufactures, and distributes evidence-based products linking the gut and human health through the Company owned brands, such as Activated Nutrients and Activated Probiotics. Activated Nutrients offers a range of completely organic, plant-based, all in-one nutritional products. Activated Probiotics offers a range of clinically backed precision probiotics. Activated Probiotics provides live biotherapeutic products clinically proven to help prevent and support the management of various health concerns, including low mood and sleep, bone health, iron malabsorption, mild eczema through randomized double-blind placebo-controlled trials. Activated Probiotics products include Biome Acne Probiotic, Biome Baby Probiotic, Biome Eczema Probiotic, and Biome Acne Probiotic.

Employees

Sector

Pharmaceuticals

More about the company